Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis
Open accessThe DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Acute myocarditis covers a wide spectrum of clinical presentations, from uncomplicated myocarditis to severe forms complicated by hemodynamic instability and ventricular arrhythmias; however, all these forms are characterized by acute myocardial inflammation. The term “chronic inflammatory cardiomyopathy” describes a persistent/chronic inflammatory condition with a clinical phenotype of dilated and/or hypokinetic cardiomyopathy associated with symptoms of heart failure and increased risk for arrhythmias. A continuum can be identified between these two conditions. The importance of early diagnosis has grown markedly in the contemporary era with various diagnostic tools available. While cardiac magnetic resonance (CMR) is valid for diagnosis and follow-up, endomyocardial biopsy (EMB) should be considered as a first-line diagnostic modality in all unexplained acute cardiomyopathies complicated by hemodynamic instability and ventricular arrhythmias, considering the local expertise. Genetic counseling should be recommended in those cases where a genotype–phenotype association is suspected, as this has significant implications for patients’ and their family members’ prognoses. Recognition of the pathophysiological pathway and clinical “red flags” and an early diagnosis may help us understand mechanisms of progression, tailor long-term preventive and therapeutic strategies for this complex disease, and ultimately improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during EAM, dysregulated macrophage–cardiomyocyte interactions impair contractility and exacerbate tissue damage [3,8,10].”
From Cardiac Macrophages Exhibit Dynamic Heterogeneity and Functional Specialization During Experimental Autoimmune Myocarditis. (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Currently, standard non-specific immunosuppressive therapies risk silencing reparative macrophage populations, highlighting the critical need to map specific functional subsets and their spatial niches for precision immunomodulation [3,10,16].”
From Cardiac Macrophages Exhibit Dynamic Heterogeneity and Functional Specialization During Experimental Autoimmune Myocarditis. (2026) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · cited 1×
“GCM is a rare disorder presenting often with a fulminant course requiring a prompt histological diagnosis and immediate immunosuppressive treatment [16].”
BackgroundCaforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479 · cited 3×
“Subsequent studies have clarified the efficacy of immunosuppression in terms of cardiac function but not in terms of survival benefit [127] and therapy often remains eminence-rather than evidence-based.”
Background2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844 · cited 1×
“To date, it remains to be clarified whether an inflammatory trigger is the “primum movens” that determines cardiomyocytes’ damage, necrosis, and the consequent repair process with fibrofatty infiltration or if inflammation is rather a reactive phenomenon following myocyte loss [98].”
BackgroundCardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel-Aty, H., Gutberlet, M., Prasad, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,509
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308 · cited 1×
“More frequently, it occurs in the presence of systemic autoimmune diseases such as Eosinophilic granulomatosis with polyangiitis (EGPA), hypersensitivity reaction to drugs, in the rare hypereosinophilic syndrome with the myeloproliferative or idiopathic form, or in the case of parasitic infections.”
BackgroundAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
BackgroundA Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274 · cited 1×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
Background
Cited by
Netala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024) · Cells · doi:10.3390/cells13171471 · Cited by 236
Przytuła, N., Podolec, J., Przewłocki, T., Podolec, P. S., & Kabłak-Ziembicka, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211003 · Cited by 14
Inflammatory cardiomyopathy: an update for clinicians
Imazio, M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.07.003 · Cited by 9
Zhuang, Y., Yan, Y., Zheng, W., Rao, X., Jiang, J., Li, H., & Wang, D. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103970 · Cited by 8
“…in intensive care and immunomodulatory therapies have reduced acute mortality from myocarditis, a substantial proportion of survivors progress to chronic inflammatory cardiomyopathy characterized by persistent low-grade inflammation, ventricular dilation, and fibrotic remodeling [11,25,26].”
Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up
Esmel-Vilomara, R., Riaza, L., Dolader, P., Rodríguez‐Santiago, B., Lasa‐Aranzasti, A., Muñoz‐Cabello, P., Fernández‐Álvarez, P., Figueras-Coll, M., Bianco, L., Bueno-Gómez, A., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133255 · Cited by 7
Jiang, F., Tang, J., Wei, X., Pan, H., Fan, X., Zhang, P., & Guo, S. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01062-9 · Cited by 5
Mitrokhin, V. M., Kamkin, A. G., Babkina, I., Savinkova, I. G., Shileiko, S. A., Сергеевич, О. Р., & Mladenov, M. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062603 · Cited by 6
“TNF-α mediates leukocyte adhesion, endothelial activation, and matrix remodeling [112].”
Daoud, A., Kalinoski, H., Talor, M. V., Welsh, R. A., Jo, W., Jaime, C. M., Kolim, B., Mahto, N., Kveton, M., Weislová, I., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf209 · Cited by 4
Zeb, R., Chinome, D. V. C., Chacon, M., Singh, T., Chowdary, M. M., Vidals, C. J. M., Mehnaz, S., Medina, A. F. T., Gadde, P. S., lingamgunta, R. P. K., et al. (2024) · Cureus · doi:10.7759/cureus.76478 · Cited by 4
Raza, S., Wang, L., Yu, H., Haroon, M., Malik, M. O., Basit, A., Awan, K. M., & Ahmad, D. (2026) · Emergent Materials · doi:10.1007/s42247-026-01427-2 · Cited by 3
The Emerging Roles of Resolvins: Potential Diagnostic Biomarkers for Cardiovascular Diseases
Bolat, R., & Yazgan, B. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x370785250417015007 · Cited by 3
“Chronic illnesses such as heart failure, inflammatory cardiomyopathy, and autoimmune-related cardiac disorders are significantly impacted by persistent inflammation, which is frequently mediated by pro-inflammatory cytokines [33-35].”
Predictors of long-term adverse course in acute myocarditis: a multicentre cohort study
Li, G., Li, Z., Li, F., & Jiang, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf672 · Cited by 3
A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View
Jawaid, S., Joshi, Y., Neelofar, N., Khursheed, K., Shams, S., Chaudhary, M., Arora, M., Mahajan, K., & Anwar, F. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128347223241021111914 · Cited by 2
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?
Correale, M., Bevere, E. M. L., Tricarico, L., Villani, D., Granato, M., Guerriero, E., Capasso, R., Rossi, L., Rotondo, C., Cantatore, F. P., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15081029 · Cited by 1
“It is particularly recommended in cases of ventricular arrhythmias, myocarditis, or pericarditis presenting as acute heart failure [136,137].”
Irrera, N., Filippis, L. D., Labellarte, D., Freni, J., Santoro, G., Favaloro, A., Nicita, F., Centofanti, A., & Vermiglio, G. (2025) · Cells · doi:10.3390/cells14211679 · Cited by 2
“Inflammation plays a pivotal role in the pathogenesis of SSc, both systemically and within target organs [9–11].”
Awais, M., Baroudi, M., Mankani, M. H., Ali, A., Khokhar, M. E., Shaukat, N., Haider, S. U., Zafar, A. A., & Roa, L. A. M. (2025) · Cureus · doi:10.7759/cureus.99835 · Cited by 1
“Similarly, pericarditis in autoimmune disorders such as systemic lupus erythematosus results from autoantibody production and complement activation, which sustain pericardial inflammation and fibrosis [13].”
Yang, C., Li, Z., Zhao, Z., & Guo, Z. (2026) · Reviews in Medical Virology · doi:10.1002/rmv.70097 · Cited by 1
Targeting Autoimmune Myocarditis with Lemon Balm Extract: In Vivo Molecular Approach
Draginic, N. D., Andjic, M. M., Nikolic, M. R., Kočović, A. G., Novakovic, J. N., Sretenovic, J. Z., Živković, V., Jakovljevic, V. L., Bolevich, S., & Milosavljević, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114761 · Cited by 1
“Regulatory T cells (Tregs), crucial for immune homeostasis in EAM, act partly via IL-10 and TGF-β secretion [1,4].”
Ciaccio, E. J., Hsia, H. H., Talke, M., Schwartz, S. M., Garan, H., Yarmohammadi, H., Peters, N. S., Coromilas, J., & BIVIANO, A. B. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.017 · Cited by 2
Optimized cardiac leukocyte isolation for flow cytometry enumeration and sorting
Olabiyi, A. A., Cakir, S. N., Kassai, M., Sriramula, S., Kennedy, L., Meher, A. K., Bhowmick, D., & Brás, L. E. D. C. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00137.2026 · Cited by 1
Stefanska, M., Kot, M., Koterba, D., & Zeyland, J. (2026) · Cells · doi:10.3390/cells15121110
“Currently, standard non-specific immunosuppressive therapies risk silencing reparative macrophage populations, highlighting the critical need to map specific functional subsets and their spatial niches for precision immunomodulation [3,10,16].”
InfluentialA Unique Case of Goodpasture’s Syndrome-Induced Cardiorenal Syndrome
Chinniah, C., Pyronneau, A., Stepman, G., & Ali, R. K. (2024) · Cureus · doi:10.7759/cureus.64269
“…three weeks after the initial clinical presentation, endomyocardial biopsy, which remains the gold-standard technique to diagnose acute myocarditis [16] and reveals an inflammatory infiltrate with necrosis or degeneration of adjacent myocytes, markers of myocyte injury and inflammation such as…”
BackgroundCHRONIC MYOCARDITIS: MODERN VIEW ON THE PROBLEM OF DIAGNOSIS AND TREATMENT
Ovcharenko, L. K., Tsyganenko, I. V., Cherkun, M. P., & Buhaievska, M. O. (2025) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.25.2.274
Osei, N., Agyekum, A. K., Lin, F., & Bukharovich, I. F. (2025) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1010006
Martinez, M., Kim, S., Bonatti, J. O., Wagner, W. R., & Riviere, C. N. (2025) · Journal of Medical Devices · doi:10.1115/1.4068896
Acute left ventricle disfunction with chamber thrombi in Loeffler syndrome
Murawska, A., Hordyński, G., Woźniak, J., Gierlotka, M. J., & Wojdyła‐Hordyńska, A. (2025) · In a good rythm · doi:10.5604/01.3001.0055.0133
Diagnosis of acute myocarditis with myocardial delayed enhancement on CTA: a case report
Liu, Z., & Wang, Y. (2025) · Exploration of Cardiology · doi:10.37349/ec.2025.101277
Breiter, P. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-47700
Factors Affecting Aortic Root Diameter in Ankylosing Spondylitis
Brifkani, A. M., & Saadalla, B. (2025) · Journal Of Biochemical Technology · doi:10.51847/mihoslxehn
OTSTAVNYH, D., Fedorchenko, Y., & Koreneva, T. A. (2025) · Медицинский вестник МВД · doi:10.52341/20738080_2025_134_1_45
Rei, R., Esteves, B., Ferreira, C. C., Oliveira, J., Beirão, T., Tenazinha, C., Duarte, A. C., & Santos, M. J. (2026) · ARP Rheumatology · doi:10.63032/csqz3453
Multimodality Imaging in Myocarditis: Integrating Etiology, Diagnosis, and Risk Stratification
Cheikh-Debs, D., Rushworth, P., Liu, J., Lee, C., Moslehi, J. J., & Salerno, M. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02374-4
“In the chronic phase, established fibrosis and ventricular remodeling predomi - nate, typically with resolution of edema and inflammation [10, 11].”
Pan, J., Zhang, Y., Guo, Y., Li, H., Zhang, F., Niu, M., Xiong, H., Chen, C., Yang, H., Guan, H., et al. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1810814
“Their occurrence may be influenced by myocardial maturation, structural heart disease, inflammatory triggers, and external stressors (3, 4).”
Myocardial injury in systemic lupus erythematosus and lupus nephritis: a silent threat
Moysidou, E., Bazmpani, M.-A., Kallifatidis, A., Kotzadamis, D., Pagourelias, E., Karamitsos, T., Stangou, M., & Frangou, E. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag305
“It is generally reserved for selected clinical scenarios where non-invasive methods cannot provide a clear diagnosis or when histology would significantly alter therapeutic management [ 50 , 93 , 94 ].”
Mechanisms of cardiovascular defects due to endotheliotropic virus infection
Gill, J., Tappia, P. S., & Dhalla, N. S. (2026) · Scripta Medica · doi:10.5937/scriptamed57-68604
“…cardio-myopathy requires the understanding of temporal sequence of infarct-like injury which acts as the acute instigator to pave the way for chronic, non-ischaemic remodelling, 28, 29 this article discusses the phases in which they proceed to drive the development of cardiovascular abnormalities.”
DIAGNOSTIC APPROACH OF MYOCARDITIS
Angerer, A.-K., Mūraitė, G., & Šerpytis, P. (2026) · Sveikatos mokslai · doi:10.35988/sm-hs.2026.261
Li, S., Zhang, X., Wang, J., Tao, J., Guo, R., Zhang, H., Ma, Y., Yue, S., Liu, G., 王, 金., et al. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-07718-1
Myokarditis im Kindes- und Jugendalter: Rückkehr zum Sport – wann ist sie sicher möglich?
Oberhoffer, F. S., & Dalla‐Pozza, R. (2026) · Kinder- und Jugendmedizin · doi:10.1055/a-2827-7663
Bevere, E. M. L., Peppo, M. D., Tricarico, L., Costabile, E., Cafagna, S., Crudo, A. F., Gulino, G., Santagata, F., Oukani, I., Stolfo, G. D., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13110549
Metadata
- Authors
- Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M.
- Affiliations
- Alessandro Manzoni Hospital (IT)
- Policlinico Tor Vergata (IT)
- University Hospital Zurich (CH)
- St Bartholomew's Hospital (GB)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Beltrami, Matteo
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-12-27
- Volume
- 13
- Issue
- 1
- Pages
- 150
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC10780032
- OpenAlex
- W4390273166
- Cited by
- 33
- References
- 133
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 4
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Use Siena air (University of Siena) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- acute myocarditis, dilated cardiomyopathy, heart failure, ventricular arrhythmias, hemodynamic instability, cardiac magnetic resonance, endomyocardial biopsy, genotype-phenotype correlation, genetic counseling, pathophysiology, disease progression, early diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.